About TheraCUES
TheraCUES is a company based in Bengaluru (India) founded in 2016 by Gopalakrishna Ramaswamy. TheraCUES has raised $86.3 thousand across 3 funding rounds. TheraCUES offers products and services including Digital Spatial Profiling, Targeted Gene Expression, Cell-Line Authentication, Bioinformatics Insights, and Extraction Services. TheraCUES operates in a competitive market with competitors including HueDx and BioTalentum, among others.
- Headquarter Bengaluru, India
- Founders Gopalakrishna Ramaswamy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Theracues Innovations Private Limited
- Date of Incorporation 25 Nov, 2016
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$381.95 K (USD)93.58as on Mar 31, 2022
-
Net Profit
$9.51 K (USD)226.89as on Mar 31, 2022
-
EBITDA
$38.86 K (USD)253.84as on Mar 31, 2022
-
Total Equity Funding
$86.3 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TheraCUES
TheraCUES offers a comprehensive portfolio of products and services, including Digital Spatial Profiling, Targeted Gene Expression, Cell-Line Authentication, Bioinformatics Insights, and Extraction Services.
Enables deeper insights from tissue samples for research applications.
Detects up to 800 gene targets for clinical and basic research.
Ensures accuracy and integrity of cell lines in experiments.
Converts research data into actionable decisions and visualizations.
Provides accurate RNA and DNA extraction for molecular assays.
Offers specialized problem-solving for unique research needs.
Funding Insights of TheraCUES
TheraCUES has successfully raised a total of $86.3K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by TheraCUES
Investment portfolio details for TheraCUES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TheraCUES
Detailed financials for TheraCUES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Theracues Comparisons
Peer comparison for TheraCUES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TheraCUES
TheraCUES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HueDx and BioTalentum, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a cloud-based diagnostic platform for clinicians
|
|
| Locked | Locked | Locked |
Human stem-cell technologies for drug testing and toxicology are provided.
|
Detailed competitors of TheraCUES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Theracues
Complete news archive for TheraCUES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TheraCUES
TheraCUES was founded in 2016 and raised its 1st funding round 1 year after it was founded.
TheraCUES is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Gopalakrishna Ramaswamy is the current CEO of TheraCUES. They have also founded this company.
TheraCUES is a funded company, having raised a total of $86.3K across 3 funding rounds to date.
Annual revenue of TheraCUES is $381.95K as on Mar 31, 2022.
TheraCUES was founded in 2016 and is based in Bengaluru, India. Tools and solutions are offered for translational research in precision medicine, with emphasis on disease detection and targeted therapy. Genetic signatures, digital spatial profiling, cell line authentication, gene expression analysis, and bioinformatics insights are utilized in operations. Services support advancements in biotechnology and healthcare sectors.
TheraCUES's top competitors include HueDx and BioTalentum.
TheraCUES offers Digital Spatial Profiling, Targeted Gene Expression, Cell-Line Authentication, Bioinformatics Insights, and 2 more products and services.